Determining a future policy focus to support antimicrobial stewardship in community pharmacy: A modified Delphi study

被引:0
|
作者
Lim, Kathryn [1 ]
Lum, Elaine [2 ]
Olsen, Anna [3 ]
Nissen, Lisa [4 ]
Broom, Alex [5 ]
Seale, Holly [1 ]
机构
[1] Univ New South Wales, Sch Populat Hlth, Level 2,Samuels Bldg, Randwick, NSW 2031, Australia
[2] Natl Univ Singapore, Duke NUS Med Sch, Singapore, Singapore
[3] Australian Natl Univ, ANU Coll Hlth & Med, Canberra, Australia
[4] Univ Queensland, Ctr Business & Econ Hlth, Woolloongabba, Australia
[5] Univ Sydney, Sch Social & Polit Sci, Sydney, Australia
来源
EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY | 2024年 / 14卷
关键词
Antimicrobial stewardship; Antimicrobial resistance; Pharmacy; Pharmacists; Qualitative research; Policy; CONSENSUS;
D O I
10.1016/j.rcsop.2024.100456
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Over the past decade, the pharmacy sector's policy, academic and professional spheres have increasingly drawn attention to the opportunities to better leverage the untapped potential of the community pharmacy sector in contributing to global efforts to reduce antimicrobial resistance (AMR). While efforts are in train, progress is slow. Objective: To draw insights from global experts in the field to identify a broad range of potential future policy directions to support community pharmacists' involvement in antimicrobial stewardship (AMS). Methods: A modified Delphi technique, comprising two survey rounds to build consensus amongst global community pharmacy sector stakeholders and opinion leaders. In Round 1, participants rated their level of agreement with 28 statements across the three domains of policy design, implementation design, and monitoring and evaluation. Participants were also invited to contribute feedback in Round 1, which was reflected as new statements (n = 10) in Round 2. In Round 2, participants were asked to re-assess Round 1 statements in view of the group consensus and to rate the new statements. Results: 289 participants were invited to participate. 48/289 (17% response rate) completed Round 1, and 25/42 (60% response rate) completed Round 2. Consensus (defined as >70% agreement) was achieved for 79% (n = 30) of the statements across the three domains. Conclusion: Pharmacy sector experts agreed that acknowledging community pharmacists in AMS national action plans is an important component, signalling a recognition of the sector's contribution to whole-of-nation AMS efforts. Implementation components that achieved consensus reflect the profession's evolution to a professional service driven model, particularly in complementary AMS initiatives including infection prevention and control measures. Context-specific adjustments to support implementing these AMS measures will be required, in addition to striking the appropriate balance to support the pace of increased community pharmacists'involvement in AMS with building whole-of-profession buy-in.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Critical Steps for Determining Capacity to Refuse Emergency Medical Services Transport: A Modified Delphi Study
    Carrillo, Eli A.
    Ignell, Steven P.
    Wulfovich, Sharon
    Vernon, Michael J.
    Sebok-Syer, Stefanie S.
    PREHOSPITAL EMERGENCY CARE, 2024,
  • [32] Determining nursing research priorities in lao people's democratic republic: A modified delphi study
    Aungsuroch, Yupin
    Songnavong, Chanheme
    Tantikosoom, Pachanat
    Phanpaseuth, Souksavanh
    Sisoulath, Anousone
    Gunawan, Joko
    Koy, Virya
    Khamlunvilaivong, Dalasouk
    NURSING AND MIDWIFERY STUDIES, 2020, 9 (03) : 157 - 162
  • [33] Clinical risk assessment of modelled situations in a pharmaceutical decision support system: a modified e-Delphi exploratory study
    Bouet, Juline
    Potier, Arnaud
    Michel, Bruno
    Mongaret, Celine
    Ade, Mathias
    Dony, Alexandre
    Larock, Anne-Sophie
    Dufay, Edith
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (03) : 727 - 735
  • [34] Antimicrobial therapy of community-acquired pneumonia during stewardship efforts and a coronavirus pandemic: an observational study
    Bjørn Waagsbø
    Morten Tranung
    Jan Kristian Damås
    Lars Heggelund
    BMC Pulmonary Medicine, 22
  • [35] Antimicrobial therapy of community-acquired pneumonia during stewardship efforts and a coronavirus pandemic: an observational study
    Waagsbo, Bjorn
    Tranung, Morten
    Damas, Jan Kristian
    Heggelund, Lars
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [36] Community pharmacists' views on their current role and future opportunities for antibiotic stewardship: a French qualitative study
    Essilini, Anais
    Pierre, Amelie
    Bocquier, Aurelie
    Pulcini, Celine
    Wilcke, Christophe
    Gravoulet, Julien
    Demore, Beatrice
    Thilly, Nathalie
    JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (03):
  • [37] A Delphi study and ranking exercise to support commissioning services: future delivery of Thrombectomy services in England
    Halvorsrud, Kristoffer
    Flynn, Darren
    Ford, Gary A.
    McMeekin, Peter
    Bhalla, Ajay
    Balami, Joyce
    Craig, Dawn
    White, Phil
    BMC HEALTH SERVICES RESEARCH, 2018, 18
  • [38] A Delphi study and ranking exercise to support commissioning services: future delivery of Thrombectomy services in England
    Kristoffer Halvorsrud
    Darren Flynn
    Gary A. Ford
    Peter McMeekin
    Ajay Bhalla
    Joyce Balami
    Dawn Craig
    Phil White
    BMC Health Services Research, 18
  • [39] Relevance of assessment items in community paramedicine home visit programmes: results of a modified Delphi study
    Leyenaar, Matthew S.
    Allana, Amir
    Sinha, Samir K.
    Nolan, Michael
    Agarwal, Gina
    Tavares, Walter
    Costa, Andrew P.
    BMJ OPEN, 2021, 11 (11):
  • [40] Current Status of Outpatient Oral Antimicrobial Prescription and the Influence of Antimicrobial Stewardship for Inpatients: A Repeated Cross-Sectional Study at a Japanese Community Hospital
    Tsuchimoto, Daisuke
    Morioka, Hiroshi
    Imaizumi, Takahiro
    Miyagawa, Sawako
    Yamamoto, Masashi
    Onishi, Katsuhiro
    Kuwabara, Yukinori
    Takada, Kazuto
    Watamoto, Koichi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (09) : 1340 - 1346